References:

<HIDE>

[1]Budihardjo, I., Oliver, H., Lutter, M., Luo, X., Wang, X., 1999. Biochemical pathways of caspase activation during apoptosis. Annu. Rev. Cell Dev. Biol., 15:269-290.

[2]Chen, K., Zhao, H., Hu, Z., Wang, L.E., Zhang, W., Sturgis, E.M., Wei, Q., 2008. Casp3 polymorphisms and risk of squamous cell carcinoma of the head and neck. Clin. Cancer Res., 14(19):6343-6349.

[3]Degterev, A., Boyce, M., Yuan, J., 2003. A decade of caspases. Oncogene, 22(53):8543-8567.

[4]Enjuanes, A., Benavente, Y., Bosch, F., Martin-Guerrero, I., Colomer, D., Perez-Alvarez, S., Reina, O., Ardanaz, M.T., Jares, P., Garcia-Orad, A., et al., 2008. Genetic variants in apoptosis and immunoregulation-related genes are associated with risk of chronic lymphocytic leukemia. Cancer Res., 68(24):10178-10186.

[5]Fan, C., Jin, M., Chen, K., Zhang, Y., Zhang, S., Liu, B., 2007. Case-only study of interactions between metabolic enzymes and smoking in colorectal cancer. BMC Cancer, 7:115.

[6]Frank, B., Hemminki, K., Wappenschmidt, B., Meindl, A., Klaes, R., Schmutzler, R.K., Bugert, P., Untch, M., Bartram, C.R., Burwinkel, B., 2006. Association of the casp10 v410i variant with reduced familial breast cancer risk and interaction with the casp8 d302h variant. Carcinogenesis, 27(3):606-609.

[7]Gaudet, M.M., Milne, R.L., Cox, A., Camp, N.J., Goode, E.L., Humphreys, M.K., Dunning, A.M., Morrison, J., Giles, G.G., Severi, G., et al., 2009. Five polymorphisms and breast cancer risk: results from the breast cancer association consortium. Cancer Epidemiol. Biomarkers Prev., 18(5):1610-1616.

[8]Grutter, M.G., 2000. Caspases: key players in programmed cell death. Curr. Opin. Struct. Biol., 10(6):649-655.

[9]Haiman, C.A., Garcia, R.R., Kolonel, L.N., Henderson, B.E., Wu, A.H., le Marchand, L., 2008. A promoter polymorphism in the casp8 gene is not associated with cancer risk. Nat. Genet., 40(3):259-260.

[10]Hajra, K.M., Liu, J.R., 2004. Apoptosome dysfunction in human cancer. Apoptosis, 9(6):691-704.

[11]Hakim, I.A., Chow, H.H., Harris, R.B., 2008. Green tea consumption is associated with decreased DNA damage among gstm1-positive smokers regardless of their hogg1 genotype. J. Nutr., 138(8):1567S-1571S.

[12]Han, S., Lee, K.M., Choi, J.Y., Park, S.K., Lee, J.Y., Lee, J.E., Noh, D.Y., Ahn, S.H., Han, W., Kim, D.H., et al., 2008. Casp8 polymorphisms, estrogen and progesterone receptor status, and breast cancer risk. Breast Cancer Res. Treatment, 110(2):387-393.

[13]Hosgood, H.D.3rd, Baris, D., Zhang, Y., Zhu, Y., Zheng, T., Yeager, M., Welch, R., Zahm, S., Chanock, S., Rothman, N., et al., 2008. Caspase polymorphisms and genetic susceptibility to multiple myeloma. Hematol. Oncol., 26(3):148-151.

[14]Hosgood, H.D., Baris, D., Zhang, Y., Berndt, S.I., Menashe, I., Morton, L.M., Lee, K.M., Yeager, M., Zahm, S.H., Chanock, S., 2009. Genetic variation in cell cycle and apoptosis related genes and multiple myeloma risk. Leukemia Res., 33(12):1609-1614.

[15]Huxley, R.R., Ansary-Moghaddam, A., Clifton, P., Czernichow, S., Parr, C.L., Woodward, M., 2009. The impact of dietary and lifestyle risk factors on risk of colorectal cancer: a quantitative overview of the epidemiological evidence. Int. J. Cancer, 125(1):171-180.

[16]Kawai, Y., Matsui, Y., Kondo, H., Morinaga, H., Uchida, K., Miyoshi, N., Nakamura, Y., Osawa, T., 2008. Galloylated catechins as potent inhibitors of hypochlorous acid-induced DNA damage. Chem. Res. Toxicol., 21(7):1407-1414.

[17]Kleinbaum, D.G., 2002. Epidemiologic methods: the “Art” in the state of the art. J. Clin. Epidemiol., 55(12):1196-1200.

[18]Kumar, S., 2007. Caspase function in programmed cell death. Cell Death Differ., 14(1):32-43.

[19]Kuzuhara, T., Tanabe, A., Sei, Y., Yamaguchi, K., Suganuma, M., Fujiki, H., 2007. Synergistic effects of multiple treatments, and both DNA and RNA direct bindings on, green tea catechins. Mol. Carcinog., 46(8):640-645.

[20]Lan, Q., Zheng, T., Chanock, S., Zhang, Y., Shen, M., Wang, S.S., Berndt, S.I., Zahm, S.H., Holford, T.R., Leaderer, B., et al., 2006. Genetic variants in caspase genes and susceptibility to non-hodgkin lymphoma. Carcinogenesis, 28(4):823-827.

[21]Lan, Q., Morton, L.M., Armstrong, B., Hartge, P., Menashe, I., Zheng, T., Purdue, M.P., Cerhan, J.R., Zhang, Y., Grulich, A., et al., 2009. Genetic variation in caspase genes and risk of non-hodgkin lymphoma: a pooled analysis of 3 population-based case-control studies. Blood, 114(2):264-267.

[22]Li, C., Zhao, H., Hu, Z., Liu, Z., Wang, L.E., Gershenwald, J.E., Prieto, V.G., Lee, J.E., Duvic, M., Grimm, E.A., et al., 2008. Genetic variants and haplotypes of the caspase-8 and caspase-10 genes contribute to susceptibility to cutaneous melanoma. Hum. Mut., 29(12):1443-1451.

[23]Liu, B., Zhang, Y., Jin, M., Ni, Q., Liang, X., Ma, X., Yao, K., Li, Q., Chen, K., 2010. Association of selected polymorphisms of CCND1, p21, and caspase8 with colorectal cancer risk. Mol. Carcinog., 49(1):75-84.

[24]Liu, C.Y., Wu, M.C., Chen, F., Ter-Minassian, M., Asomaning, K., Zhai, R., Wang, Z., Su, L., Heist, R.S., Kulke, M.H., et al., 2010. A large-scale genetic association study of esophageal adenocarcinoma risk. Carcinogenesis, 31(7):1259-1263.

[25]Nasiri, H., Forouzandeh, M., Rasaee, M.J., Rahbarizadeh, F., 2005. Modified salting-out method: high-yield, high-quality genomic DNA extraction from whole blood using laundry detergent. J. Clin. Lab. Anal., 19(6):229-232.

[26]Nicholson, D.W., Thornberry, N.A., 1997. Caspases: killer proteases. Trends Biochem. Sci., 22(8):299-306.

[27]Oh, J.E., Kim, M.S., Ahn, C.H., Kim, S.S., Han, J.Y., Lee, S.H., Yoo, N.J., 2010. Mutational analysis of CASP10 gene in colon, breast, lung and hepatocellular carcinomas. Pathology, 42(1):73-76.

[28]Pittman, A.M., Broderick, P., Sullivan, K., Fielding, S., Webb, E., Penegar, S., Tomlinson, I., Houlston, R.S., 2008. Casp8 variants d302h and −652 6N ins/del do not influence the risk of colorectal cancer in the United Kingdom population. Br. J. Cancer, 98(8):1434-1436.

[29]Skol, A.D., Scott, L.J., Abecasis, G.R., Boehnke, M., 2006. Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies. Nat. Genet., 38(2):209-213.

[30]Srivastava, K., Srivastava, A., Mittal, B., 2010. Caspase-8 polymorphisms and risk of gallbladder cancer in a Northern Indian population. Mol. Carcinog., 49(7):684-692.

[31]Sun, T., Gao, Y., Tan, W., Ma, S., Shi, Y., Yao, J., Guo, Y., Yang, M., Zhang, X., Zhang, Q., et al., 2007. A six-nucleotide insertion-deletion polymorphism in the casp8 promoter is associated with susceptibility to multiple cancers. Nat. Genet., 39(5):605-613.

[32]Sung, J.J., Lau, J.Y., Goh, K.L., Leung, W.K., 2005. Increasing incidence of colorectal cancer in Asia: implications for screening. Lancet Oncol., 6(11):871-876.

[33]Ter-Minassian, M., Zhai, R., Asomaning, K., Su, L., Zhou, W., Liu, G., Heist, R.S., Lynch, T.J., Wain, J.C., Lin, X., et al., 2008. Apoptosis gene polymorphisms, age, smoking and the risk of non-small cell lung cancer. Carcinogenesis, 29(11):2147-2152.

[34]Thomas, D., Xie, R., Gebregziabher, M., 2004. Two-stage sampling designs for gene association studies. Genet. Epidemiol., 27(4):401-414.

[35]Ulybina, Y.M., Kuligina, E., Mitiushkina, N.V., Rozanov, M.E., Ivantsov, A.O., Ponomariova, D.N., Togo, A.V., Levchenko, E.V., Shutkin, V.A., Brenister, S.I., et al., 2009. Coding polymorphisms in casp5, casp8 and dr4 genes may play a role in predisposition to lung cancer. Cancer Lett., 278(2):183-191.

[36]Wang, Z.B., Liu, Y.Q., Cui, Y.F., 2005. Pathways to caspase activation. Cell Biol. Int., 29(7):489-496.

[37]Wang, H., Thomas, D.C., Pe'er, I., Stram, D.O., 2006. Optimal two-stage genotyping designs for genome-wide association scans. Genet. Epidemiol., 30(4):356-368.

[38]Wu, Y., Jin, M., Liu, B., Liang, X., Yu, Y., Li, Q., Ma, X., Yao, K., Chen, K., 2011. The association of XPC polymorphisms and tea drinking with colorectal cancer risk in a Chinese population. Mol. Carcinog., 50(3):189-198.

[39]Yang, L., Parkin, D.M., Ferlay, J., Li, L., Chen, Y., 2005. Estimates of cancer incidence in china for 2000 and projections for 2005. Cancer Epidemiol. Biomarkers Prev., 14(1):243-250.

[40]Yang, G., Shu, X.O., Li, H., Chow, W.H., Ji, B.T., Zhang, X., Gao, Y.T., Zheng, W., 2007. Prospective cohort study of green tea consumption and colorectal cancer risk in women. Cancer Epidemiol. Biomarkers Prev., 16(6):1219-1223.

[41]Yee, Y.K., Gu, Q., Hung, I., Tan, V.P., Chan, P., Hsu, A., Pang, R., Lam, C.S., Wong, B.C., 2010. Trend of colorectal cancer in Hong Kong: 1983-2006. J. Gastroenterol. Hepatol., 25(5):923-927.

[42]Zhang, Z., Xu, Y., Zhou, J., Wang, X., Wang, L., Hu, X., Guo, J., Wei, Q., Shen, H., 2005. Polymorphisms of thymidylate synthase in the 5′- and 3′-untranslated regions associated with risk of gastric cancer in south china: a case-control analysis. Carcinogenesis, 26(10):1764-1769.

[43]Zhang, Y., Liu, B., Jin, M., Ni, Q., Liang, X., Ma, X., Yao, K., Li, Q., Chen, K., 2009. Genetic polymorphisms of transforming growth factor-β1 and its receptors and colorectal cancer susceptibility: a population-based case-control study in china. Cancer Lett., 275(1):102-108.